GlassScriptPhysician profile
Ryan D Horsley
NPI 1497079206
$10,165.33
in general payments reported to CMS, 2019-2025
18 companies · $1,877 in 2025
The $1,877 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.08 · 2021: $4,760 · 2022: $711 · 2023: $1,948 · 2024: $825 · 2025: $1,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,519 · Travel and Lodging: $2,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,518.57 |
| Travel and Lodging | $2,131.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,260.11 | 2019-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,768.27 | 2023-2025 | Spyglass, Spyglass Discover, General - Therapies |
| Medical Device Business Services, INC. | $1,333.21 | 2023 | |
| W. L. Gore & Associates, INC. | $282.49 | 2024-2025 | Gore Propaten Vascular Graft, Gore Enform Preperitoneal Biomaterial |
| Smith+Nephew, INC. | $226.73 | 2022-2024 | Stravix, Grafix, Oasis |
| Endogastric Solutions, INC | $196.94 | 2022-2023 | Esophyx |
| Stryker Corporation | $170.17 | 2025 | 1788 |
| Coloplast Corp | $144.14 | 2023 | Sensura Mio |
| Davol INC. | $127.71 | 2022 | |
| Conmed Corporation | $111.16 | 2023 | Airseal |
| Atricure, INC. | $101.86 | 2024 | |
| Haemonetics Corporation | $94.65 | 2022 | |
| Medtronic, INC. | $82.25 | 2024 | Endoflip |
| Revance Therapeutics, INC. | $80.63 | 2024 | Daxxify |
| Merit Medical Systems INC | $75.94 | 2024 | Esophyx |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reshape Lifesciences INC. | $52.18 | 2023 | |
| Integra Lifesciences Corporation | $37.84 | 2024 | Integra, Surgimend, Omnigraft |
| Xeris Pharmaceuticals, INC. | $19.05 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Horsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.